{"organizations": [], "uuid": "b6173d6cf27d7387da3c127d54ae08e3c57539f1", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "https://www.reuters.com/legal", "section_title": "Legal News | Reuters", "url": "https://www.reuters.com/article/health-meningitis/u-s-seeks-35-year-prison-term-for-pharmacist-in-meningitis-outbreak-idUSL2N1PO1PG", "country": "US", "domain_rank": 408, "title": "U.S. seeks 35-year prison term for pharmacist in meningitis outbreak", "performance_score": 0, "site": "reuters.com", "participants_count": 1, "title_full": "", "spam_score": 1.0, "site_type": "news", "published": "2018-01-30T05:08:00.000+02:00", "replies_count": 0, "uuid": "b6173d6cf27d7387da3c127d54ae08e3c57539f1"}, "author": "Reuters Editorial", "url": "https://www.reuters.com/article/health-meningitis/u-s-seeks-35-year-prison-term-for-pharmacist-in-meningitis-outbreak-idUSL2N1PO1PG", "ord_in_thread": 0, "title": "U.S. seeks 35-year prison term for pharmacist in meningitis outbreak", "locations": [], "entities": {"persons": [{"name": "glenn chin", "sentiment": "none"}], "locations": [{"name": "u.s.", "sentiment": "none"}, {"name": "massachusetts", "sentiment": "none"}, {"name": "boston", "sentiment": "none"}], "organizations": [{"name": "new england compounding center", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "Federal prosecutors are seeking a 35-year prison term for a Massachusetts pharmacist convicted on racketeering and fraud charges over his role in a 2012 fungal meningitis outbreak that killed 76 people and sickened hundreds more.\nProsecutors in a brief filed on Friday in federal court in Boston said Glenn Chin, as New England Compounding Centerâ€™s supervisory pharmacist, oversaw the dispensing of thousands of substandard and dangerous drugs manufactured in filthy conditions.\nTo read the full story on WestlawNext Practitioner Insights, click here: bit.ly/2rRUSoS\n ", "external_links": ["http://bit.ly/2rRUSoS", "http://thomsonreuters.com/en/about-us/trust-principles.html"], "published": "2018-01-30T05:08:00.000+02:00", "crawled": "2018-01-30T03:31:15.004+02:00", "highlightTitle": ""}